(Q34550245)

3 August 2017

Pharmacokinetics and safety of solifenacin succinate in healthy young men. (English)

1 reference

3 August 2017

1 reference

Ronald A Smulders

1

1 reference

3 August 2017

Walter J Krauwinkel

series ordinal

2

1 reference

3 August 2017

Pieter J Swart

series ordinal

3

1 reference

3 August 2017

Moses Huang

series ordinal

4

1 reference

3 August 2017

language of work or name

1 reference

1 September 2004

1 reference

The Journal of Clinical Pharmacology

3 August 2017

1 reference

3 August 2017

44

1 reference

3 August 2017

9

1 reference

3 August 2017

1023-1033

1 reference

How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study

3 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F0091270004267592

21 January 2018

The overactive bladder

1 reference

https://api.crossref.org/works/10.1177%2F0091270004267592

The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004267592

Pharmacologic options for the overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004267592

Muscarinic receptor antagonists in the treatment of overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004267592

Effects of YM905, a novel muscarinic M3-receptor antagonist, on experimental models of bowel dysfunction in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004267592

M(3) receptor antagonism by the novel antimuscarinic agent solifenacin in the urinary bladder and salivary gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004267592

21 January 2018

Identifiers

DOI

10.1177/0091270004267592

1 reference

3 August 2017

1 reference